Biochemistry and Molecular Biology Seminar

Monday, October 30, 2017

1:00 PM-2:00 PM

Topic
Inhibition of Parkinson’s Protein Leucine-Rich Repeat Kinase 2 (LRRK2) by an FDA-approved Compound

Presented By
Iban Ubarretxena-Belandia, PhD, associate professor of pharmacological sciences; co-director, PhD Program in Biophysics & Systems Pharmacology, Icahn School of Medicine at Mount Sinai

Hosted By
Shae Padrick, PhD, assistant professor, Biochemistry and Molecular Biology

Contact Information

Lucia Boyer
lb32@drexel.edu